LONZA GROUP AG-REG (1LONN.MI) Stock Price, Forecast & Analysis
Europe - Euronext Milan - BIT:1LONN - CH0013841017 - Common Stock
1LONN.MI Key Statistics, Chart & Performance
The current stock price of 1LONN.MI is 570 EUR.
1LONN.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| DIM.PA | SARTORIUS STEDIM BIOTECH | 50.9 | 21.35B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 51.69 | 21.69B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 57.28 | 19.56B | ||
| SRT.DE | SARTORIUS AG | 44.85 | 15.31B | ||
| QIA.DE | QIAGEN N.V. | 19.98 | 8.80B | ||
| 1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 15.71 | 2.30B | ||
| EVT.DE | EVOTEC SE | N/A | 2.25B | ||
| GXI.DE | GERRESHEIMER AG | 7.46 | 950.54M | ||
| FF.MI | FINE FOODS & PHARMACEUTICALS | 10.38 | 203.83M | ||
| ALECR.PA | EUROFINS CEREP-REGR | 24.9 | 178.00M | ||
| MLC.I | MALIN CORP PLC | N/A | 33.34M |
Related stock screener links
About 1LONN.MI
Company Profile
Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. The company is headquartered in Basel, Basel-Stadt and currently employs 19,299 full-time employees. The company went IPO on 2002-04-03. The firm's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The firm divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.
Company Info
LONZA GROUP AG-REG
Muenchensteinerstrasse 38
Basel BASEL-STADT CH
Employees: 19299
Phone: 41613168111
LONZA GROUP AG-REG / 1LONN.MI FAQ
What does LONZA GROUP AG-REG do?
Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. The company is headquartered in Basel, Basel-Stadt and currently employs 19,299 full-time employees. The company went IPO on 2002-04-03. The firm's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The firm divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.
What is the stock price of LONZA GROUP AG-REG today?
The current stock price of 1LONN.MI is 570 EUR. The price increased by 0.88% in the last trading session.
Does LONZA GROUP AG-REG pay dividends?
LONZA GROUP AG-REG (1LONN.MI) has a dividend yield of 0.74%. The yearly dividend amount is currently 4.29.
How is the ChartMill rating for LONZA GROUP AG-REG?
1LONN.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Is LONZA GROUP AG-REG (1LONN.MI) expected to grow?
The Revenue of LONZA GROUP AG-REG (1LONN.MI) is expected to grow by 14.34% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is LONZA GROUP AG-REG worth?
LONZA GROUP AG-REG (1LONN.MI) has a market capitalization of 40.03B EUR. This makes 1LONN.MI a Large Cap stock.
Can you provide the ownership details for 1LONN stock?
You can find the ownership structure of LONZA GROUP AG-REG (1LONN.MI) on the Ownership tab.
1LONN.MI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 1LONN.MI.
1LONN.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1LONN.MI. 1LONN.MI has only an average score on both its financial health and profitability.
1LONN.MI Financial Highlights
Over the last trailing twelve months 1LONN.MI reported a non-GAAP Earnings per Share(EPS) of 16.64. The EPS increased by 16.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.33% | ||
| ROA | 3.9% | ||
| ROE | 8.5% | ||
| Debt/Equity | 0.49 |
1LONN.MI Forecast & Estimates
30 analysts have analysed 1LONN.MI and the average price target is 749.2 EUR. This implies a price increase of 31.44% is expected in the next year compared to the current price of 570.
For the next year, analysts expect an EPS growth of 11.82% and a revenue growth 14.34% for 1LONN.MI